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control subjects that could have limited the observed exercise 
capacity in the patients. 
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Reply 
The aim of our study was not to list known potential influences on 
Doppler diastolic indexes but to relate those indexes to the patient's 
professed symptomatic status and exercise capacity so that each 
patient in effect served as his or her own control. Our patient group 
was closely matched with a normal group for comparison of Doppler 
indexes and exercise capacity. No patient had significant mitral 
incompetence and all had normal findings on coronary angiography 
at a time unrelated to the current study. Although beta-adrenergic 
blocking agents may have a limiting effect on oxygen uptake in 
trained men (I), in patients with hypertrophic cardiomyopathy, 
these agents have a beneficial effect on diastolic function and patient 
symptoms (2,3). Verapamil is more likely to alter diastolic indexes 
and has a tendency to normalize them (4). However, only four of our 
patients were taking verapamil during the study and their inclusion 
does not influence our results in 40 patients. 
JACC Vol. 20. No.5 
November 1. 1992 
PETROS NIHOYANNOPOULOS, MD, FACC 
CELIA M. OAKLEY, MD, FRCP, FACC 
Royal Postgraduate Medical School 
Hammersmith Hospital 
Du Cane Road 
London W12 OHS, England 
References 
I. Tesch PA. Kaiser P. Effect of bela-adrenergic blockade on maximal oxygen uptake in 
trained males. Acta Physiol Scand 1981 ;112:351-3. 
2. Swanton RH. Brooksby lAB. Jenkins BS. Webb-Peploe MM. Haemodynamic studies 
on beta blockade in hypertrophic obstructive cardiomyopathy. Eur J Cardiol 1977;5: 
327. 
3. Alvarez RP. Goodwin JF. Noninvasive assessment of diastolic function in hypertrophic 
cardiomyopathy on and off beta adrenergic blocking drugs. Br Heart J 1982;48:204. 
4. Bonow RO. Dilsizian V. Rosino DR. et aI. Verapamil·induced improvement in left 
vent~cular ~iastolic filling and increased exercise tolerance in patients .... ith hyper-
trophIc cardIomyopathy: short- and long-term effects. Circulation 1985;72:853-64. 
Correction 
A correction should be made to Table 2 in the article by Rihal et al. 
in the May issue of the Journal (Rihal CS, Gersh BJ, Whisnant JP, 
et al. Influence of coronary heart disease on morbidity and mortality 
after carotid endarterectomy: a population-based study in Olmsted 
County, Minnesota [1970-1988]. J Am Coll Cardiol 1992;19:1254-
60). The numbers in the last line of Table 2 were incorrectly 
transposed from Table 1. The authors apologize for the error and 
provide the following corrected version: 
Table 2: Distribution of All Postoperative Cardiac Events Through 
July I, 1989 Among Olmsted County Residents Who Underwent 
Carotid Endarterectomy During the Period 1970 to 1988 
Group I Group 2 Group 3 Total 
No. % No. % No. % No. % 
Cardiac death 8 9 IS 23 6 30 29 16 
Myocardial infarction 13 14 20 31 5 25 38 21 
CABG orPTCA 4 4 19 30 4 20 27 15 
Pulmonary edema 4 4 7 II 5 12 7 
Ventricular tachycardia 3 3 9 14 3 15 15 8 
Patients with ~ I event 21 23 40 63 10 50 71 40 
Definitions and abbreviations as in 'Table I. 
